BRCA 1 /2 and / or HRD

Clinical trials for BRCA 1 /2 and / or HRD explained in plain language.

Never miss a new study

Get alerted when new BRCA 1 /2 and / or HRD trials appear

Sign up with your email to follow new studies for BRCA 1 /2 and / or HRD, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New drug combo hopes to tackle Hard-to-Treat cancers

Disease control Recruiting now

This early-phase study tests a new oral drug called SYN818 combined with olaparib in 110 adults with advanced solid tumors, including ovarian and breast cancers that have BRCA mutations or related DNA repair problems. The main goals are to find a safe dose and check for side effe…

Matched conditions: BRCA 1 /2 AND / OR HRD

Phase 1 • Sponsor: Hangzhou SynRx Therapeutics Biomedical Technology Co., Ltd • Aim: Disease control

Last updated Jun 26, 2026 14:17 UTC

BRCA 1 /2 and / or HRD

Get alerted when new BRCA 1 /2 and / or HRD trials appear

New drug combo hopes to tackle Hard-to-Treat cancers